12.03.2021 • NewsOMV

OMV Plans Glycerin-to-Propanol Pilot Plant

Austrian energy and chemicals company OMV has announced plans to invest about €30 million in a pilot plant that will produce propanol from glycerin. Construction is planned to start in the second quarter of 2021, with the plant due to go into operation in 2023.

“After more than five years of research, we are now investing in a ‘Glycerin2Propanol’ pilot plant and thereby contribute to the further development of advanced biofuels. The new plant will be part of the existing value chain in the Schwechat Refinery and is an additional building block in OMV’s sustainable business model,” said OMV chief downstream operations officer Thomas Gangl.

Glycerin is a byproduct or waste product from producing biodiesel, as well as making detergents and soaps, but it is also considered an advanced feedstock under the European Union’s Renewable Energy Directive (RED) II. The propanol produced in this way will be used as a bio-additive for gasoline. It can also be used as a sustainable feedstock for chemicals, replacing fossil-based propanol.

The facility will be built next to the ReOil plant at Schwechat so that both can use a single measuring station and exploit synergistic effects. It will use a catalyst developed inhouse by OMV and have an annual capacity of 1.25 million liters, leading to a CO2 reduction of about 1,800 t.

The long-term plan is to commercialize the technology and produce around 125 million liters of propanol per year and reduce CO2 emissions by about 180,000 t. The Austrian Research Promotion Agency is providing funds of about €6.9 million in the project.

Author: Elaine Burridge, Freelance Journalist

Austria’s OMV will invest about €30 million in a pilot plant at its...
Austria’s OMV will invest about €30 million in a pilot plant at its Schwechat refinery that will produce propanol from glycerin. The facility will be built next to the ReOil plant and have an annual capacity of 1.25 million liters. It is due to be operational in 2023. (c) OMV

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.